Potential factors of interorgan signals in the development of pancreatitis-associated acute lung injury and acute respiratory distress syndrome

Journal of Organ Dysfunction

Volumn 1, Issue 1, 2005, Pages 32-44

  Zhao, Hong ^a   Zhao, Xia ^a   Bai, Chunxue ^a   Wang, Xiangdong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

acute pancreatitis; ARDS; cytokines; inflammation; leucocytes; lung injury

Indexed keywords

EID: 33645796018     PISSN: 17471060     EISSN: 17471079     Source Type: Journal    
DOI: 10.1080/17471060500223365     Document Type: Article

References (96)

1. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American–European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818–824
2. Gattinoni L, Pelosi P, Suter PM, Pedoto A, Vercesi P, Lissoni A. Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease: different syndromes?. Am J Respir Crit Care Med 1998; 158: 3–11
3. Rau B, Pralle U, Uhl W, Schoenberg MH, Beger HG. Management of terile necrosis in instances of severe acute pancreatitis. J Am Coll Surg 1995; 181: 279–288
4. Stenberg W, Tenner S. Acute pancreatitis. N Engl J Med 1994; 330: 1198–1210
5. Neoptolemos JP, Raraty M, Finch M, Sutton R. Acute pancreatitis: the substantial human and financial costs. Gut 1998; 42: 886–891
6. Raraty MGT, Connor S, Criddle DN, Dphil RS, Neoptolemos JP. Acute pancreatitis and organ failure: pathophysiology, natural history, and management strategies. Curr Gastroenterol Rep 2004; 6: 99–103
7. Johnson CD, Kingsnorth AN, Imrie CW, McMahon MJ, Neoptolemos JP, et al. Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis. Gut 2001; 48: 62–69
8. Uhl W, Buchler MW, Malfertheiner P, Beger HG, Adler G, Gaus W. A randomised, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis. Gut 1999; 45: 97–104
9. Mutinga M, Rosenbluth A, Tenner SM, Odze RR, Sica GT, Banks PA. Does mortality occur early or late in acute pancreatitis?. Int J Pancreatol 2000; 28: 91–95
10. McKay CJ, Evans S, Sinclair M, Carter CR, Imrie CW. High early mortality rate from acute pancreatitis in Scotland, 1984–1305. Br J Surg 1999; 86: 1302–5
11. Renner IG, Savage WT, Pantoja JL, Renner VJ. Death due to acute pancreatitis: a retrospective analysis of 405 autopsy cases. Dig Dis Sci 1985; 30: 1005–1018
12. Banks PA. Pancreatitis. Topics in gastroenterology, HM Spiro. Plenum Medical, New York 1979; 1–45
13. Robertson CS, Basran GS, Hardy JG. Lung vascular permeability in patients with acute pancreatitis. Pancreas 1988; 3: 162–165
14. Leveau, P, Wang, XD, Sun, ZW, Börjesson, A, Andersson, E, Andersson, A. R. Severity of pancreatitis-associated gut barrier dysfunction is reduced following treatment with the PAF inhibitor lexipafant. Biochem Pharm 2005; 69: 1325–1331.
15. Wang XD, Bäjesson A, Sun ZW, Wallen R, Deng XM, Zhang HY, et al. The association of type II pneumocytes and endothelial permeability with the pulmonary custocyte system in experimental acute pancreatitis. Eur J Clin Invest 1997; 27: 936–942
16. Andersson R, Wang XD. Patterns of pancreatic cell death: apoptosis versus oncosis. Pancreas 1998; 17: 281–288
17. Zhao X, Andersson R, Wang X, Dib M, Wang XD. Acute pancreatitis-associated lung injury: pathophysiological mechanisms and potential future therapies. Scand J Gastroenterol 2002; 37: 1351–1358
18. Axelsson J, Wang XD, Andersson R. Novel understanding of pathophysiology and potential intervention in acute pancreatitis based on studies of gene-modified mice. Scand J Gastroenterol 2004; 39: 409–415
19. Pastor CM, Matthay MA, Frossard JL. Pancreatitis-associated acute lung injury: new insights. Chest 2003; 124: 2341–2351
20. Shi, CB, Andersson, R, Zhao, X, Wang, XD. Potential role of reactive oxygen species in pancreatitis-associated multiple organ dysfunction. Pancreatology 2005; 5: 492–500.
21. Salomone T, Tosi P, Di Battista N, Binetti N, Raiti C, Tomassetti P, et al. Impaired alveolar gas exchange in acute pancreatitis. Dig Dis Sci 2002; 47: 2025–2028
22. Di Carlo V, Nespoli A, Chiesa R, Staudacher C, Cristallo M, Bevilacqua G, Staudacher V. Hemodynamic and metabolic impairment in acute pancreatitis. World J Surg 1981; 5: 329–339
23. Oettinger W, Beger HG. Hemodynamic changes in acute pancreatitis. Acute pancreatitis, HG Beger, M Buchler. Springer, Berlin 1987; 207–210
24. Tsai K, Wang SS, Chen TS, Kong CW, Chang FY, Lee SD, Lu FJ. Oxidative stress: an important phenomenon with pathogenetic significance in the progression of acute pancreatitis. Gut 1998; 42: 850–855
25. Telek G, Regoly-Merei J, Kovacs GC, Simon L, Nagy Z, Hamar J, Jakab F. The first histological demonstration of pancreatic oxidative stress in human acute pancreatitis. Hepatogastroenterology 2001; 48: 1252–1258
26. Knoefel WT, Kollias N, Warshaw AL, Waldner H, Nishioka NS, Rattner DW. Pancreatic microcirculatory changes in experimental pancreatitis of graded severity in the rat. Surgery 1994; 116: 904–913
27. Wang XD, Andersson R, Kruse P, Ihse I. Carbon dioxide transport in rats with acute pancreatitis. Int J Pancreatol 1996; 19: 103–112
28. Andersson R, Wang XD. Gut barrier dysfunction in experimental acute pancreatitis. Ann Acad Med Singapore 1999; 28: 141–146
29. Coskun T, Bozoklu S, Ozenc A, Ozdemir A. Effect of hydrogen peroxide on permeability of the main pancreatic duct and morphology of the pancreas. Am J Surg 1998; 176: 53–58
30. Poch B, Gansauge F, Rau B, Wittel U, Gansauge S, Nussler AK, et al. The role of polymorphonuclear leukocytes and oxygen-derived free radicals in experimental acute pancreatitis: mediators of local destruction and activators of inflammation. FEBS Lett 1999; 461: 268–272
31. Dabrowski A, Gabryelewicz A. Oxidative stress. An early phenomenon characteristic of acute experimental pancreatitis. Int J Pancreatol 1992; 12: 193–199
32. Frossard JL, Hadengue A, Spahr L, Morel P, Pastor CM. Natural history of long-term lung injury in mouse experimental pancreatitis. Crit Care Med 2002; 30: 1541–1546
33. Dib M, Zhao X, Wang X, Andersson E, Drewsen G, Andersson R. Acute phase response in acute pancreatitis: a comparison with abdominal sepsis. Scand J Gastroenterol 2003; 38: 1072–1077
34. Rau B, Poch B, Gansauge F, Bauer A, Nussler AK, Nevalainen T, et al. Pathophysiologic role of oxygen free radicals in acute pancreatitis: initiating event or mediator of tissue damage?. Ann Surg 2000; 231: 352–360
35. Hartwig W, Carter EA, Jimenez RE, Werner J, Fischman AJ, Fernandez-Del Castillo C, Warshaw AL. Chemotactic peptide uptake in acute pancreatitis: correlation with tissue accumulation of leukocytes. J Appl Physiol 1999; 87: 743–749
36. Werner J, Dragotakes SC, Fernandez-del Castillo C, Rivera JA, Ou J, Rattner DW, et al. Technetium-99m-labeled white blood cells: anew method to define the local and systemic role leukocytes in acute experimental pancreatitis. Ann Surg 1998; 227: 86–94
37. Bhatia M, Saluja AK, Hofbauer B, Lee HS, Frossard JL, Steer ML. The effects of neutrophil depletion on a completely noninvasive model of acute pancreatitis-associated lung injury. Int J Pancreatol 1998; 24: 77–83
38. Guice KS, Oldham KT, Caty MG, Johnson KJ, Ward PA. Neutrophil-dependent oxygen-radical mediated lung injury associated with acute pancreatitis. Ann Surg 1989; 210: 740–747
39. Hartwig W, Carter EA, Jimenez RE, Jones R, Fischman AJ, Castillo CF, Warshaw AL. Neutrophil metabolic activity but not neutrophil sequestration reflects the development of pancreatitis-associated lung injury. Crit Care Med 2002; 30: 2075–2082
40. Minutoli L, Altavilla D, Marini H, Passaniti M, Bitto A, Seminara P, et al. Protective effects of SP600125 a new inhibitor of c-jun N-terminal kinase (JNK) and extracellular-regulated kinase (ERK1/2) in an experimental model of cerulein-induced pancreatitis. Life Sci 2004; 75: 2853–2866
41. Andersson R, Wang X, Ihse I. The influence of abdominal sepsis on acute pancreatitis in rats: a study on mortality, permeability, arterial pressure, and intestinal blood flow. Pancreas 1995; 11: 365–373
42. Gerard C, Frossard JL, Bhatia M, Saluja A, Gerard NP, Lu B, Steer M. Targeted disruption of the b-chemokine receptor CCR1 protects against pancreatitis-associated lung injury. J Clin Invest 1997; 100: 2022–2027
43. Kahrau S, Schneider P, Loddenkemper C, Buhr HJ, Foitzik T. Pulmonary microcirculation in mild and severe experimental pancreatitis. Eur Surg Res 2003; 35: 402–407
44. Bhatnagar A, Wig JD, Majumdar S. Expression of activation, adhesion molecules and intracellular cytokines in acute pancreatitis. Immunol Lett 2001; 77: 133–141
45. Yu WK, Li WQ, Li N, Li JS. Mononuclear histocompatibility leukocyte antigen-DR expression in the early phase of acute pancreatitis. Pancreatology 2004; 4: 233–243
46. Mentula P, Kylanpaa ML, Kemppainen E, Jansson SE, Sarna S, Puolakkainen P, et al. Plasma anti-inflammatory cytokines and monocyte human leucocyte antigen-DR expression in patients with acute pancreatitis. Scand J Gastroenterol 2004; 39: 178–187
47. de la Mano AM, Sevillano S, Manso MA, Perez M, de Dios I. Cholecystokinin blockade alters the systemic immune response in rats with acute pancreatitis. Int J Exp Pathol 2004; 85: 75–84
48. Hartwig W, Jimenez RE, Fernandez-del Castillo C, Kelliher A, Jones R, Warshaw AL. Expression of the adhesion molecules Mac-1 and L-selectin on neutrophils in acute pancreatitis is protease- and complement-dependent. Ann Surg 2001; 233: 371–378
49. Lundberg AH, Granger N, Russell J, Callicutt S, Gaber LW, Kotb M, et al. Temporal correlation of tumor necrosis factor-alpha release, upregulation of pulmonary ICAM-1 and VCAM-1, neutrophil sequestration, and lung injury in diet-induced pancreatitis. J Gastrointest Surg 2000; 4: 248–257
50. Zhao X, Dib M, Andersson E, Shi CB, Widegren B, Wang XD, Andersson R. Alterations of adhesion molecule expression and inflammatory mediators in acute lung injury induced by septic and non-septic challenges. Lung 2005; 183: 87–100
51. Mann DV, Kalu P, Foulds S, Edwards R, Glazer G. Neutrophil activation and hyperamylasemia after endoscopic retrograde cholangiopancreatography: potential role for the leukocyte in the pathogenesis of acute pancreatitis. Endoscopy 2001; 33: 453–488
52. McGill SN, Ahmed NA, Hu F, Micheln RP, Christou NV. Shedding of l-selectin as a mechanism for reduced polymorphonuclear neutrophil exudation in patients with the systemic inflammatory response syndrome. Arch Surg 1996; 131: 1141–1147
53. Telek G, Ducroc R, Scoazec JY, Pasquier C, Feldmann G, Roze C. Differential upregulation of cellular adhesion molecules at the sites of oxidative stress in experimental acute pancreatitis. J Surg Res 2001; 96: 56–67
54. Zhao, X, Dib, M, Wang, XD, Widegren, B, Andersson, R. The influence of mast cells on the expression of adhesion molecules on circulating and migrating leukocytes in acute pancreatitis-associated lung injury. Lung 2005.
55. Wang XD, Sun Z, Borjesson A, Andersson R. Inhibition of platelet-activating factor, intercellular adhesion molecule 1 and platelet endothelial cell adhesion molecule 1 reduces experimental pancreatitis-associated gut endothelial barrier dysfunction. Br J Surg 1999; 86: 411–416
56. Dib M, Zhao X, Wang XD, Andersson R. Role of mast cells in the development of pancreatitis-induced multiple organ dysfunction. Br J Surg 2002; 89: 172–178
57. Steer ML. Relationship between pancreatitis and lung diseases. Respir Physiol 2001; 128: 13–16
58. Gomez-Cambronero LG, Sabater L, Pereda J, Cassinello N, Camps B, Vina J, Sastre J. Role of cytokines and oxidative stress in the pathophysiology of acute pancreatitis: therapeutical implications. Curr Drug Targets Inflamm Allergy 2002; 1: 393–403
59. Jiang CF, Shiau YC, Ng KW, Tan SW. Serum interleukin-6, tumor necrosis factor alpha and C-reactive protein in early prediction of severity of acute pancreatitis. J Chin Med Assoc 2004; 67: 442–446
60. Ramudo L, Manso MA, De Dios I. Biliary pancreatitis-associated ascitic fluid activates the production of tumor necrosis factor-alpha in acinar cells. Crit Care Med 2005; 33: 143–148
61. Balog A, Gyulai Z, Boros LG, Farkas G, Takacs T, Lonovics J, Mandi Y. Polymorphism of the TNF-alpha, HSP70-2, and CD14 genes increases susceptibility to severe acute pancreatitis. Pancreas 2005; 30: e46–e50
62. Dugernier TL, Laterre PF, Wittebole X, Roeseler J, Latinne D, Reynaert MS, Pugin J. Compartmentalization of the inflammatory response during acute pancreatitis: correlation with local and systemic complications. Am J Respir Crit Care Med 2003; 168: 148–157
63. Pereda J, Sabater L, Cassinello N, Gomez-Cambronero L, Closa D, Folch-Puy E, et al. Effect of simultaneous inhibition of TNF-alpha production and xanthine oxidase in experimental acute pancreatitis: the role of mitogen activated protein kinases. Ann Surg 2004; 240: 108–116
64. Mentula P, Kylanpaa ML, Kemppainen E, Jansson SE, Sarna S, Puolakkainen P, et al. Early prediction of organ failure by combined markers in patients with acute pancreatitis. Br J Surg 2005; 92: 68–75
65. Penalva JC, Martinez J, Laveda R, Esteban A, Munoz C, Saez J, et al. A study of intestinal permeability in relation to the inflammatory response and plasma Endocab IgM levels in patients with acute pancreatitis. J Clin Gastroenterol 2004; 38: 512–517
66. Paszkowski AS, Rau B, Mayer JM, Moller P, Beger HG. Therapeutic application of caspase 1/interleukin-1beta-converting enzyme inhibitor decreases the death rate in severe acute experimental pancreatitis. Ann Surg 2002; 235: 68–76
67. Kimura Y, Hirota M, Okabe A, Inoue K, Kuwata K, Ohmuraya M, Ogawa M. Dynamic aspects of granulocyte activation in rat severe acute pancreatitis. Pancreas 2003; 27: 127–132
68. Wang XD, Andersson R, Soltezs V, Ihse I. Gut origin sepsis, macrophage function, and oxygen extraction in acute pancreatitis in the rat. World J Surg 1996; 20: 299–308
69. Dervenis C, Smailis D, Hatzitheoklitos E. Bacterial translocation and its prevention in acute pancreatitis. J Hepatobiliary Pancreat Surg 2003; 10: 415–418
70. Isenmann R, Rau B, Beger HG. Bacterial infection and extent of necrosis are determinants of organ failure in patients with acute necrotizing pancreatitis. Br J Surg 1999; 86: 1020–1024
71. Takahashi H, Tsuda Y, Takeuchi D, Kobayashi M, Herndon DN, Suzuki F. Influence of systemic inflammatory response syndrome on host resistance against bacterial infections. Crit Care Med 2004; 32: 1879–1885
72. Severgnini M, Takahashi S, Rozo LM, Homer RJ, Kuhn C, Jhung JW, et al. Activation of the STAT pathway in acute lung injury. Am J Physiol Lung Cell Mol Physiol 2004; 286: L1282–L1292
73. Mikami Y, Takeda K, Shibuya K, Qiu-Feng H, Shimamura H, Yamauchi J, et al. Do peritoneal macrophages play an essential role in the progression of acute pancreatitis in rats?. Pancreas 2003; 27: 253–260
74. Lane JS, Todd KE, Gloor B, Chandler CF, Kau AW, Ashley SW, et al. Platelet activating factor antagonism reduces the systemic inflammatory response in a murine model of acute pancreatitis. J Surg Res 2001; 99: 365–370
75. Pastor CM, Rubbia-Brandt L, Hadengue A, Jordan M, Morel P, Frossard JL. Role of macrophage inflammatory peptide-2 in cerulein-induced acute pancreatitis and pancreatitis-associated lung injury. Lab Invest 2003; 83: 471–478
76. Sakai Y, Masamune A, Satoh A, Nishihira J, Yamagiwa T, Shimosegawa T. Macrophage migration inhibitory factor is a critical mediator of severe acute pancreatitis. Gastroenterology 2003; 124: 725–736
77. Paajanen H, Laato M, Jaakkola M, Pulkki K, Niinikoski J, Nordback I. Serum tumor necrosis factor compared with C reactive protein in the early assessment of severity of acute pancreatitis. Br J Surg 1995; 82: 271–273
78. Brivet FG, Emilie D, Galanaud P. Pro and anti inflammatory cytokines during acute severe pancreatitis: an early and sustained response, although impredictable of death. Crit Care Med 1999; 27: 749–755
79. de Dios I, Perez M, de la Mano A, Sevillano S, Orfao A, Ramudo L, Manso M A. Contribution of circulating leukocytes to cytokine production in pancreatic duct obstruction-induced acute pancreatitis in rats. Cytokine 2002; 20: 295–303
80. Rau B, Baumgart K, Kruger CM, Schilling M, Beger HG. CC-chemokine activation in acute pancreatitis: enhanced release of monocyte chemoattractant protein-1 in patients with local and systemic complications. Intensive Care Med 2003; 29: 622–629
81. Montravers P, Chollet-Martin S, Marmuse JP, Gougerot-Pocidalo MA, Desmonts JM. Lymphatic release of cytokines during acute lung injury complicating severe pancreatitis. Am J Respir Crit Care Med 1995; 152: 1527–1533
82. Gloor B, Blinman TA, Rigberg DA, Todd KE, Lane JS, Hines OJ, Reber HA. Kupffer cell blockade reduces hepatic and systemic cytokine levels and lung injury in hemorrhagic pancreatitis in rats. Pancreas 2000; 21: 414–420
83. Rinderknecht H. Acute necrotizing pancreatitis and its complications and excessive reaction of natural defense mechanisms?. The pathogenesis of acute pancreatitis ed by Braganza M. Manchester University Press, Manchester 1991; 86–100
84. Bardaji CDM, Prats HN, Fernandez-Cruz EGL, Rosello-Catafau J. Hepatic involvement in pancreatitis-induced lung damage. Am J Physiol 1996; 270: G6–13
85. Gloor B, Todd KE, Lane JS, Lewis MP, Reber HA. Hepatic Kupffer cell blockade reduces mortality of acute hemorrhagic pancreatitis in mice. J Gastrointest Surg 1998; 2: 430–435
86. Gallagher SF, Yang J, Baksh K, Haines K, Carpenter H, Epling-Burnette PK, et al. Acute pancreatitis induces FasL gene expression and apoptosis in the liver. J Surg Res 2004; 122: 201–209
87. Bhatia M, Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 2004; 202: 145–156
88. Papachristou GI, Whitcomb DC. Predictors of severity and necrosis in acute pancreatitis. Gastroenterol Clin North Am 2004; 33: 871–890
89. Buchler M, Malfertheiner P, Schadlich H, Nevalainen TJ, Friess H, Berger HG. Role of phospholipase A2 in human acute pancreatitis. Gastroenterology 1989; 97: 1521–1526
90. Lungarella G, Gardi C, de Santi MM, Luzi P. Pulmonary vascular injury in pancreatitis: evidence for a major role plaid by pancreatic elastase. Exp Mol Pathol 1985; 42: 44–59
91. Tahamont MV, Barie PS, Blumenstock FA, Hussain MH, Malik AB. Increased lung vascular permeability after pancreatitis and trypsin infusion. Am J Pathol 1982; 109: 15–26
92. Hartwig W, Werner J, Jimenez RE, Z'graggen K, Weimann J, Lewandrowski KB, et al. Trypsin and activation of circulating trypsinogen contribute to pancreatitis-associated lung injury. Am J Physiol 1999; 277: G1008–G1016
93. Jaffray C, Wang J, Carter G, Mendez C, Norman J. Pancreatic elastase activates pulmonary nuclear factor kappa B and inhibitory kappa B, mimicking pancreatitis-associated adult respiratory distress syndrome. Surgery 2000; 128: 225–231
94. Denham W, Yang J, Wang H, Botchkina G, Tracey KJ, Norman J. Inhibition of p38 mitogen activate kinase attenuates the severity of pancreatitis-induced adult respiratory distress syndrome. Crit Care Med 2000; 28: 2567–2572
95. Ueda T, Takeyama Y, Takase K, Hori Y, Kuroda Y, Ho HS. Hematin is one of the cytotoxic factors in pancreatitis-associated ascitic fluid that causes hepatocellular injury. Surgery 2002; 131: 66–74
96. Masamune A, Shimosegawa T, Fujita M, Satoh A, Koizumi M, Toyota T. Ascites of severe acute pancreatitis in rats transcriptionally up-regulates expression of interleukin-6 and -8 in vascular endothelium and mononuclear leukocytes. Dig Dis Sci 2000; 45: 429–437